PNC Financial Services Group
ATHE

PNC Financial Services Group’s Alterity Therapeutics ATHE Stock Holding History

PNC Financial Services Group’s Portfolio ATHE Stock Details ATHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-40
Closed -$140 – 4678
2022
Q4 		$140 Buy
+40
New +$153 ﹤0.01% 4672
2018
Q1 		– Sell
-32
Closed -$2K – 4170
2017
Q4 		$2K Hold
32
– – ﹤0.01% 3989
2017
Q3 		$0 Hold
32
– – ﹤0.01% 4133
2017
Q2 		$0 Hold
32
– – ﹤0.01% 4153
2017
Q1 		$2K Hold
32
– – ﹤0.01% 3922
2016
Q4 		$0 Hold
32
– – ﹤0.01% 3996
2016
Q3 		$2K Hold
32
– – ﹤0.01% 3798
2016
Q2 		$2K Hold
32
– – ﹤0.01% 4127
2016
Q1 		$0 Sell
32
-1
-3% -$33 ﹤0.01% 4499
2015
Q4 		$2K Hold
33
– – ﹤0.01% 4133
2015
Q3 		$2K Hold
33
– – ﹤0.01% 4254
2015
Q2 		$2K Hold
33
– – ﹤0.01% 4367
2015
Q1 		$2K Hold
33
– – ﹤0.01% 4271
2014
Q4 		$4K Hold
33
– – ﹤0.01% 3583
2014
Q3 		$4K Hold
33
– – ﹤0.01% 3492
2014
Q2 		$4K Hold
33
– – ﹤0.01% 3347
2014
Q1 		$6K Buy
+33
New +$18.2K ﹤0.01% 3182

Other funds holding ATHE

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
OMC
Old Mission Capital Chicago, Illinois $6.3B AUM 14.68% 1-Year Est. Return
TLCM
Twin Lakes Capital Management Redwood Shores, California $220M AUM 31.75% 1-Year Est. Return
PCA
Providence Capital Advisors Charlotte, North Carolina $613M AUM 17.83% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
SWM
Sugarloaf Wealth Management Duluth, Georgia $529M AUM 14.14% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

PNC Financial Services Group's ATHE Position: Q1 2023 in Review

PNC Financial Services Group sold out of Alterity Therapeutics (ATHE) in Q1 2023, closing a stake of 40 shares — an estimated $140 sold.

PNC Financial Services Group first reported a position in ATHE in Q1 2014 and held it in 17 quarters. The position peaked at $6K in Q1 2014. 7 funds tracked by Wall St. Rank hold ATHE as of Q1 2023.

  • PNC Financial Services Group reported no remaining Alterity Therapeutics position as of Q1 2023 after selling out during the quarter.
  • PNC Financial Services Group sold 40 Alterity Therapeutics shares in Q1 2023, an estimated $140.
  • PNC Financial Services Group first reported a position in Alterity Therapeutics in Q1 2014 and held it in 17 quarters.
  • PNC Financial Services Group's Alterity Therapeutics position peaked at $6K in Q1 2014.
  • 7 funds tracked by Wall St. Rank held Alterity Therapeutics as of Q1 2023.

Based on PNC Financial Services Group's 13F filing for Q1 2023, filed 15 May 2023.